Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 14/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.48 |
| ▸ | HTR2A | P28223 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | ACACB | O00763 | 2/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21276770 | 0.88 | MCHR1 (0.50) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL21276670 | 0.84 | MCHR1 (0.50) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL21276824 | 0.79 | HRH3 (0.51) | MCHR1CHRM1HTR2ACYP2D6 | |
| SCHEMBL18781681 | 0.76 | FLT3 (0.46) | MCHR1CHRM1HTR2AACACB | |
| SCHEMBL17447564 | 0.75 | RET (0.56) | — | |
| SCHEMBL21276739 | 0.74 | RAB9A (0.51) | MCHR1HPGD | |
| SCHEMBL21276708 | 0.73 | HRH3 (0.59) | CHRM1HTR2AACACB | |
| SCHEMBL7353127 | 0.73 | LTA4H (0.58) | — | |
| SCHEMBL14368318 | 0.72 | CA12 (0.58) | CHRM1HTR2ACYP2D6HPGD | |
| SCHEMBL21276827 | 0.71 | MCHR1 (0.45) | MCHR1CYP2D6ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3169671-B1 | 1-(5-(TERT.-BUTYL)ISOXAZOL-3-YL)-3-(4-((PHENYL)ETHYNYL)PHENYL)UREA DERIVATIVES AND RELATED COMPOUNDS AS FLT3 INHIBITORS FOR TREATING CANCER | SUNSHINE LAKE PHARMA CO LTD (CN) | 2019-08-21 | — | — | EP | disclosed |